CAVA
CAVA Group, Inc.
CAVA has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has a slight edge over CAVA overall, supported by stronger fundamentals and stronger valuation.
CAVA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
CAVA's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CAVA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 53x | $28.53 | -50% |
| Fair | 75x | $40.72 | -29% |
| Forward | 84x | $57.35 | — |
| Current | 106x | $57.35 | — |
| Expensive | 147x | $79.57 | +39% |
Historical ranges are pointers, not guarantees.
CAVA's PE is in its fair range at 106x. If earnings grow as analysts expect, today's price would be 84x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CAVA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for CAVA, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CAVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.69 | +27% |
| Q3 2026 | $0.54 | -53% |
| Q2 2026 | $0.55 | -54% |
| Q2 2026 | $0.52 | -57% |
| Q4 2025 | $0.54 | -51% |
CAVA has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CAVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $356.4M | +22% |
| Q2 2026 | $368.4M | +31% |
| Q2 2026 | $438.3M | +32% |
| Q4 2025 | $275M | +21% |
| Q3 2025 | $292.2M | +20% |
| Q2 2025 | $280.6M | +20% |
| Q2 2025 | $331.8M | +28% |
| Q4 2024 | $227.4M | +28% |
CAVA's revenue has grown year over year every quarter since late 2022: $356M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | -1.7 points |
| Q2 2026 | 7.3% | +0.3 points |
| Q2 2026 | 5.8% | +1 points |
| Q4 2025 | 1% | -0.7 points |
| Q3 2025 | 5.9% | +0.2 points |
| Q2 2025 | 7% | +0.1 points |
| Q2 2025 | 4.7% | +1.2 points |
| Q4 2024 | 1.7% | +2.6 points |
CAVA has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CAVA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CAVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.7M | -661% |
| Q2 2026 | $29.3M | +53% |
| Q2 2026 | $15.5M | +473% |
| Q4 2025 | $2.9M | +36% |
| Q3 2025 | $1.4M | -94% |
| Q2 2025 | $19.2M | -15% |
| Q2 2025 | $2.7M | -42% |
| Q4 2024 | $2.1M | +$9.3M |
CAVA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CAVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q4 2024 | -3.5x | Net Cash |
CAVA has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 33.6 | Neutral |
CAVA's weekly RSI is 44 (neutral) and its Stochastic is 34 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CAVA PE vs Consumer Cyclical Sector
| Metric | CAVA | Sector median | Relative |
|---|---|---|---|
| PE | 106x | 18x | 489% above |
| PE % | 62 | 36 | 26 pts above |
CAVA is trading at 106x earnings, a 489% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CAVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.7 | 3% above |
| 20 week MA | $61.8 | 7.2% below |
| 50 week MA | $69.9 | 18% below |
| 100 week MA | $77.2 | 26% below |
CAVA has stronger trend alignment. CAVA is above 1 of 4 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CAVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $38.2 | $43.0 | +13% |
| 2024 | $43.0 | $114.4 | +166% |
| 2025 | $114.4 | $60.2 | -47% |
| 2026 YTD | $60.2 | $57.4 | -4.7% |
CAVA has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.